A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.
The FDA grants pre-market approval to Cerus Corp. for its Intercept blood plasma purification device.
The FDA grants a humanitarian device exemption for CVRx's Barostim neo legacy device for treating drug-resistant hypertension.
CVRx said yesterday that it won a humanitarian device exemption from the FDA for its Barostim neo legacy device, to treat drug-resistant hypertension.
An automotive engineer is trying to raise money for a new replacement heart valve he designed by turning to crowd-funding site Indiegogo.
A Salt Lake City engineer is hoping to raise money on crowdfunding website Indiegogo to back preclinical testing of the new valve replacement technology he designed.
Royal Philips agrees to pay $1.2 billion to acquire Volcano Corp. and its cardiovascular imaging technology.
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
By Judy Wang
Google Ventures, the VC arm of the Silicon Valley tech monolith, pumped more than ⅓ of its venture spend into healthcare and life science startups during 2014.
Google (NSDQ:GOOG) took a bigger bet on healthcare in 2014, investing more than ⅓ of the its venture dollars in healthcare and life science interests, according to the company and published reports.
